Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
19.1M
-
Shares change
-
+966K
-
Total reported value, excl. options
-
$291M
-
Value change
-
+$17.7M
-
Number of buys
-
26
-
Number of sells
-
-11
-
Price
-
$15.22
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q1 2019
53 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q1 2019.
Replimune Group, Inc. - COMMON STOCK (REPL) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.1M shares
of 78.4M outstanding shares and own 24.39% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (5.1M shares), Bain Capital Life Sciences Investors, LLC (2.84M shares), Redmile Group, LLC (2.21M shares), BVF INC/IL (1.61M shares), Foresite Capital Management IV, LLC (1.23M shares), BlackRock Inc. (939K shares), Foresite Capital Management III, LLC (750K shares), EMERALD MUTUAL FUND ADVISERS TRUST (708K shares), EMERALD ADVISERS, LLC (698K shares), and Artal Group S.A. (600K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.